TOVXTheriva Biologics, Inc.

NYSE therivabio.com


$ 3.97 $ -0.13 (-3.17 %)    

Wednesday, 18-Sep-2024 11:44:54 EDT
QQQ $ 473.56 $ -1.00 (-0.21 %)
DIA $ 417.11 $ 0.21 (0.05 %)
SPY $ 563.16 $ -0.70 (-0.12 %)
TLT $ 100.36 $ 0.04 (0.04 %)
GLD $ 237.60 $ -0.59 (-0.25 %)
$ 4.1
$ 3.97
$ 4.01 x 200
-- x --
$ 3.97 - $ 3.97
$ 2.67 - $ 17.11
109,849
na
4.12M
$ 1.51
nm
TBD
na
na ($ 0.00)
na
TBD na
How to Read 10-K & 10-Q Reports To View SEC Filing Reports, Please Register or Sign In
# Filing Date Period End Date Type Report Link
1 08-13-2024 06-30-2024 10-Q
2 05-07-2024 03-31-2024 10-Q
3 03-25-2024 12-31-2023 10-K
4 11-13-2023 09-30-2023 10-Q
5 08-08-2023 06-30-2023 10-Q
6 05-11-2023 03-31-2023 10-Q
7 03-30-2023 12-31-2022 10-K
8 11-10-2022 09-30-2022 10-Q
9 08-11-2022 06-30-2022 10-Q
10 05-16-2022 03-31-2022 10-Q
11 03-16-2022 12-31-2021 10-K
12 11-03-2021 09-30-2021 10-Q
13 08-05-2021 06-30-2021 10-Q
14 05-05-2021 03-31-2021 10-Q
15 03-04-2021 12-31-2020 10-K
16 11-10-2020 09-30-2020 10-Q
17 08-06-2020 06-30-2020 10-Q
18 05-05-2020 03-31-2020 10-Q
19 02-20-2020 12-31-2019 10-K
20 11-04-2019 09-30-2019 10-Q
21 08-08-2019 06-30-2019 10-Q
22 05-08-2019 03-31-2019 10-Q
23 02-27-2019 12-31-2018 10-K
24 11-08-2018 09-30-2018 10-Q
25 08-08-2018 06-30-2018 10-Q
26 05-08-2018 03-31-2018 10-Q
27 02-22-2018 12-31-2017 10-K
28 11-01-2017 09-30-2017 10-Q
29 08-03-2017 06-30-2017 10-Q
30 05-04-2017 03-31-2017 10-Q
31 03-02-2017 12-31-2016 10-K
32 11-01-2016 09-30-2016 10-Q
33 08-03-2016 06-30-2016 10-Q
34 05-05-2016 03-31-2016 10-Q
35 03-10-2016 12-31-2015 10-K
36 11-05-2015 09-30-2015 10-Q
37 08-10-2015 06-30-2015 10-Q
38 05-11-2015 03-31-2015 10-Q
39 03-16-2015 12-31-2014 10-K
40 11-14-2014 09-30-2014 10-Q
Guide for Analyst Ratings To View Analyst Ratings, Please Register or Sign In
# Date Analyst Firm Upside/Downside Price Target Change Rating Change Current Rating

News

OPINIONS

 theriva-biologics-announces-that-the-thericel-project-has-been-awarded-funding-of-228-million-from-the-national-knowledge-transfer-program-of-the-spanish-governments-ministry-of-science-innovation--universities-to-support-a-collaboration-between-the-universitat-autnoma-de-barcelona-to-advance-the-companys-suspension-cell-platform-for-the-clinical-manufacture-of-adenovirus--and-adeno-associated-virus-therapies

Theriva™ Biologics (NYSE:TOVX), ("Theriva" or the "Company") a diversified clinical-stage company developing th...

 whats-going-on-with-theriva-biologics-stock

Theriva Biologics shares are trading higher Friday on continued momentum following a series of catalysts this week. Here's ...

 whats-going-on-with-theriva-biologics-tovx-stock

Theriva Biologics shares are trading lower by 8.4% Monday morning. The company announced a 1-for-25 reverse stock split.

 theriva-biologics-announces-1-for-25-reverse-stock-split-effective-august-26-2024

Theriva Biologics, Inc. (NYSE:TOVX), a diversified clinical-stage company developing therapeutics designed to treat diseases in...

 theriva-biologics-q2-eps-043-misses-019-estimate

Theriva Biologics (AMEX:TOVX) reported quarterly losses of $(0.43) per share which missed the analyst consensus estimate of $(0...

CLASS ACTION DEADLINES - JOIN NOW!

NEW CASE INVESTIGATION